Hepatic changes in patients with atherogenic dyslipidemia
Mel'nikova, N.V.; Zvenigorodskaia, L.A.; Khomeriki, S.G.
Eksperimental'naia i Klinicheskaia Gastroenterologiia 5: 111-119
2008
ISSN/ISBN: 1682-8658 PMID: 19145925 Document Number: 619857
Document emailed within 1 workday
Related Documents
Kas'ianenko, V.I.; Komisarenko, I.A.; Dubtsova, E.A. 2011: Correction of atherogenic dyslipidemia with honey, pollen and bee bread in patients with different body mass Terapevticheskii Arkhiv 83(8): 58-62Aronov, D.M. 1996: The role of nicotinic acid in the treatment of atherosclerosis and atherogenic dyslipidemia Klinicheskaia Meditsina 74(9): 48-52
Mete'lskaia, V.A.; Aĭngorn, E.D.; Maslennikova, G.I.; Dorofeeva, T.G.; Gorchakova, N.N.; Sipiagina, A.E.; Ruzhanskaia, T.V.; Grigo'reva, I.V.; Olfe'rev, A.M.; Beloko'n, N.A. 1989: Atherogenic dyslipidemia in adolescents: its relation to ischemic heart disease in their fathers and the possibility of its prognosis Kardiologiia 29(9): 28-34
Ogunro, P.S.; Ologunagba, P.O. 2012: Plasma level of atherogenic and anti-atherogenic factors among palm wine drinkers of rural southwest Nigeria African Journal of Medicine and Medical Sciences 41(4): 337-347
Manuthu, E.M.; Joshi, M.D.; Lule, G.N.; Karari, E. 2008: Prevalence of dyslipidemia and dysglycaemia in HIV infected patients East African Medical Journal 85(1): 10-17
Soška, V.ír. 2015: How to treat dyslipidemia in patients with metabolic syndrome Vnitrni Lekarstvi 61(7-8): 721-724
Zharfbin, A. 2006: Dyslipidemia in patients being treated with peritoneal dialysis Vnitrni Lekarstvi 52(11): 1051-1057
Rukh, G.; Ali, N.; Afzal, N.; Khan, T.S.; Shahjahan, S. 2007: Study of lipoprotein patterns as an atherogenic factor in T2DM patients and their FDRs Journal of Ayub Medical College Abbottabad: Jamc 19(4): 89-93
Asano, M.; Yamada, N. 2005: Dyslipidemia management in patients with impaired glucose tolerance Nihon Rinsho. Japanese Journal of Clinical Medicine 63(Suppl 2): 538-542
Ceccato, M.G.B.; Bonolo, P.F.; Souza Neto, A.I.; Araújo, F.S.; Freitas, M.I.F. 2011: Antiretroviral therapy-associated dyslipidemia in patients from a reference center in Brazil Brazilian Journal of Medical and Biological Research 44(11): 1177-1183
Bergesio, F.; Ciuti, R.; Innocenti, D.; Galli, G.A.; Frizzi, V. 1985: Use of pantethine in dyslipidemia of chronic uremic patients under dialysis treatment Giornale di Clinica Medica 66(11-12): 433-440
Silva, J.M.; Méndez, M.M.; Gonzalo, M.; Pinto, E. 2000: J-curve between alcohol consumption and carotid atherosclerosis in patients with dyslipidemia Anales de Medicina Interna 17(11): 582-587
Hussain, M.; Shad, M.N.; Akhtar, L. 2017: Pioglitazone attenuates cardiometabolic risk factors in non-diabetic patients with dyslipidemia JPMA. Journal of the Pakistan Medical Association 67(12): 1884-1888
Abrashkina, E.D.; Shaalali, N.; Pakhrova, O.A.; Shutemova, E.A.; Nazarova, O.A. 2010: Effect of atorvastatin on hemorheological parameters in patients with arterial hypertension with dyslipidemia Kardiologiia 50(5): 25-28
Haye Salinas, M.ía.J.; Bertoli, A.M.; Lema, L.; Saucedo, C.; Rosa, J.; Quintana, R.; Bellomio, V.ón.; Aguero, S.; Spindler, W.; Tamborenea, M.ía.N.; Schimid, M.; Ceccato, F.; Sala, J.é P.; Paira, S.; Spindler, A.; Soriano, E.R.; Estel, B.A.P.; Caeiro, F.; Alvarellos, A.; Saurit, V.ón. 2013: Prevalence of dyslipidemia and elevated cardiovascular risk in patients with rheumatoid arthritis Medicina 73(1): 26-30
Herrmann, W.; Biermann, J.; Lindhofer, H.G.; Kostner, G. 1989: Modification of the atherogenic risk factor Lp(a) by supplementary fish oil administration in patients with moderate physical training Medizinische Klinik 84(9): 429-433
Doncheva, N.I.; Nikolov, K.V.; Vassileva, D.P. 2006: Lipid-modifying and pleiotropic effects of gemfibrozil, simvastatin and pravastatin in patients with dyslipidemia Folia Medica 48(3-4): 56-61
Katyayini, R.; Benglorkar, V.M. 2016: Cross-sectional study of dyslipidemia in type 2 diabetes mellitus patients with and without associated hypothyroidism Journal of the Association of Physicians of India 64(1): 38-39
Riesen, W.F.; Descoeudres, C.; Mordasini, R.; Girod, M.A. 1989: Selective elimination of atherogenic lipoproteins using dextran-sulfate cellulose. Experiences in 2 patients with heterozygote familial hypercholesterolemia Schweizerische Medizinische Wochenschrift 119(2): 55-58
Kahya Eren, N.; Harman, E.; Dolek, D.; Emren, S.; Tütüncüoğlu, A.P.; Nazli, C.; Ergene, O. 2014: The gap between the current dyslipidemia guidelines and the physicians' treatment targets in patients with type 2 diabetes in Turkey Minerva Cardioangiologica 62(3): 287-295